Beteiligungsmeldung
Newron Pharmaceuticals S.p.A.
Gemeinsam gemeldeter Anteil
22.03%
Threshold
Crossed upwards
Timeline
Published
05.11.2015
Transaction
02.11.2015
Voting rights breakdown
Gemeldete wirtschaftlich Berechtigte · 2
Eine einzelne, gemeinsam eingereichte Meldung: Der Stimmrechtsanteil gilt für die gesamte Gruppe, nicht für jede Person.
Notice details
Meldungs-ID
TBFB300057
Beneficial owner
Investor AB
Gemeldete Adresse
Investor AB, 10332 Stockholm
Change to the composition of the group by an indirect sale resulting from an intra-group transfer within the Investor group of the shares in Duba from Investor to Patricia Industries II. For clarification,Investor remains the beneficial owner. As of the date of this notice, the Newron shares are held dIrectly by Zambon and Duba Zambon Company S.p.A. Via Lillo del Duca n. 10,20091 - Bresso (Milan), Italy, Registry of Companies of Milan n. 01690280159 ("Zambon") is an entily controlled at 85.92% by GEFIM. Duba AB, Arsenalsgatan No. 8 C, 103 32, Stockholm, Sweden, registered number 556593-5508 ( Duba ) is (as of the date of this notice, a wholly-owned direct subsidiary of Patricia Industries II AB, 103 32 Stockholm, Sweden, registered number 556619-6811 ( Patricia Industries II ). Patricia Industries II is a wholly-owned direct subsidiary of Investor. On 21 January 2013, Zambon and Duba entered into a shareholders agreement relating to their respective stakes in Newron.
insider24.ch
Verpassen Sie kein Marktsignal mehr
Mehr benötigt? Pro-Angebot entdecken